Roxana-Cristina Mehedinti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roxana-Cristina Mehedinti has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ada Stefanescu
Medical and Pharmaceutical Research Center, Faculty of Medicine and Pharmacy, “Dunărea de Jos” University of Galati, 800008 Galati, Romania
1 shared publication - Antoanela Magdalena Covaci
Faculty of Medicine and Pharmacy, Medical and Pharmaceutical Research Center, “Dunărea de Jos” University of Galați, 800008 Galati, Romania
1 shared publication - Catalin-Bogdan Satala
Faculty of Medicine and Pharmacy, Medical and Pharmaceutical Research Center, “Dunărea de Jos” University of Galați, 800008 Galati, Romania
1 shared publication - Cristian Petcu
Clinical County Emergency Hospital, 010024 Craiova, Romania
1 shared publication - Dana Tutunaru
Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, “Dunarea de Jos” University of Galati, 800008 Galati, Romania
1 shared publication - Gabriel Valeriu Popa
Faculty of Medicine and Pharmacy, Research Centre in the Field of Medical and Pharmaceutical Sciences (ReForm-UDJ), “Dunărea de Jos” University of Galați, Domnească Street, 800008 Galati, Romania
1 shared publication
Latest Publications
- Open Access
- 23 March 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (3) , 188
Dental Amalgam and Oral Biological Responses: A Narrative Review of Current Evidence
Dental amalgam remains widely used in restorative dentistry due to its durability and cost-effectiveness, yet concerns persist regarding potential biological effects related to mercury release. This narrative review critically synthesizes current evidence on oral mucosal alterations and salivary biomarker changes reported in association with amalgam restorations. Experimental research supports biological plausibility for oxidative and inflammatory responses to mercury exposure; however, most human evidence derives from observational studies demonstrating heterogeneous associations rather than consistent causal relationships. Reported variations in salivary biomarkers, including interleukin-8 and ceruloplasmin, are generally modest and influenced by confounding factors such as periodontal status, smoking, and systemic inflammation. Histopathological findings adjacent to amalgam restorations include epithelial and inflammatory changes, though many are nonspecific and comparable to other chronic irritative conditions. Overall, current clinical and epidemiological data do not indicate uniform or clinically significant adverse effects in the general population attributable solely to dental amalgam. Regulatory phase-down initiatives primarily reflect environmental and precautionary policies. Available evidence supports a balanced and evidence-based interpretation of amalgam-related biological findings in contemporary dental practice.
- 23 March 2026
- Published by MDPI AG in Dentistry Journal
- Vol. 14 (3) , 188
Open AccessDental Amalgam and Oral Biological Responses: A Narrative Review of Current Evidence
Dental amalgam remains widely used in restorative dentistry due to its durability and cost-effectiveness, yet concerns persist regarding potential biological effects related to mercury release. This narrative review critically synthesizes current evidence on oral mucosal alterations and salivary biomarker changes reported in association with amalgam restorations. Experimental research supports biological plausibility for oxidative and inflammatory responses to mercury exposure; however, most human evidence derives from observational studies demonstrating heterogeneous associations rather than consistent causal relationships. Reported variations in salivary biomarkers, including interleukin-8 and ceruloplasmin, are generally modest and influenced by confounding factors such as periodontal status, smoking, and systemic inflammation. Histopathological findings adjacent to amalgam restorations include epithelial and inflammatory changes, though many are nonspecific and comparable to other chronic irritative conditions. Overall, current clinical and epidemiological data do not indicate uniform or clinically significant adverse effects in the general population attributable solely to dental amalgam. Regulatory phase-down initiatives primarily reflect environmental and precautionary policies. Available evidence supports a balanced and evidence-based interpretation of amalgam-related biological findings in contemporary dental practice.